Home › Companies › TWIST BIOSCIENCE CORP. › 2023-2024

TWIST BIOSCIENCE CORP. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and TWIST BIOSCIENCE CORP.’s Form 8-K, filed 2024-02-07 (Item 5.07 on EDGAR). Page generated 04 October 2026.

5Reported items
258Asset managers
1,266Fund votes
2024-02-06Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore TWIST BIOSCIENCE CORP. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by TWIST BIOSCIENCE CORP.

These tallies are TWIST BIOSCIENCE CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-02-07 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

TWIST BIOSCIENCE CORP. — official shareholder meeting results, meeting held 2024-02-06
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Emily M. Leproust, Ph.D.	33,957,330	--	--	12,194,829	6,148,005	Majority: yes
Elect Director: Robert Chess	27,503,789	--	--	18,648,370	6,148,005	Majority: yes

Source: TWIST BIOSCIENCE CORP., Form 8-K, filed with the SEC on 2024-02-07 — read the filing on EDGAR.

How asset managers voted at the TWIST BIOSCIENCE CORP. 2023-2024 meeting

Each item below shows how the 258 asset managers that disclosed a TWIST BIOSCIENCE CORP. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of TWIST BIOSCIENCE CORP.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Officers, as described in the Proxy Statement under "Executive Compensation."

SECTION 14A SAY-ON-PAY VOTES

Combines 9 wordings of this item as funds reported it.

94% fund support · no official result

FOR 94%

The 246 asset managers below cast 94% of the shares they voted on this item FOR (48,936,168 for, 3,261,878 against).

FOR: 48,936,168 (93.7%)AGAINST: 3,261,878 (6.2%)ABSTAIN: 10,066 (0.0%)NOT VOTED: 1,264 (0.0%)UNKNOWN: 45 (0.0%)

Largest asset managers voting on “To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Offic” at TWIST BIOSCIENCE CORP., 2023-2024
Asset manager	For	Against	Vote
ARK ETF Trust	6,775,445	0	For
Vanguard	5,474,719	0	For
State Street	5,063,535	0	For
Artisan	4,556,371	0	For
Nikko Asset Management Americas, Inc.	3,236,355	0	For
BlackRock	3,087,700	0	For
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	2,827,175	0	For
Invesco	2,047,417	0	For
Maryland State Retirement & Pension System	2,000,000	0	For
Man Group plc	1,637,740	0	For
UBS	0	1,165,195	Against
Dimensional	1,008,613	0	For
Newton Investment Management North America, LLC	0	979,393	Against
JPMorgan	919,741	0	For
BNY Mellon	28,560	882,394	Against
Charles Schwab	896,464	0	For
WILLIAM BLAIR FUNDS	756,519	0	For
Citadel	571,412	0	For
BAILLIE GIFFORD & CO LTD	565,900	0	For
NEW YORK STATE COMMON RETIREMENT FUND	370,849	0	For
Nikko Asset Management Co., Ltd.	347,088	0	For
Fidelity	280,109	0	For
Ensign Peak Advisors, Inc	262,943	0	For
AIG/SunAmerica	261,088	0	For
Bridge Builder Trust	256,401	0	For

Showing the 25 largest of 246 asset managers. See all 246 in the interactive database.

2. Election of Class III Directors: Emily M. Leproust, Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

74% Majority: yes · of votes cast

FOR 74%WITHHELD 26%

FOR: 33,957,330WITHHELD: 12,194,829

TWIST BIOSCIENCE CORP.’s own tally for this item (“Elect Director: Emily M. Leproust, Ph.D.”): 33,957,330 for, 12,194,829 withheld, per its Form 8-K filed 2024-02-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 57,779,000 outstanding shares: 59% for, 21% withheld (80% of the company cast a for/withheld vote).

The 72 asset managers below cast 100% of the shares they voted on this item FOR (21,961,873 for, 0 against).

FOR 88%12%

FOR: 21,961,873 (87.5%)ABSTAIN: 3,130,570 (12.5%)

Largest asset managers voting on “Election of Class III Directors: Emily M. Leproust, Ph.D.” at TWIST BIOSCIENCE CORP., 2023-2024
Asset manager	For	Abstain	Vote
ARK ETF Trust	6,775,445	0	For
Vanguard	5,376,144	0	For
State Street	1,993,354	1,380	For
Artisan	1,611,932	0	For
BlackRock	1,223,059	0	For
Invesco	930,956	0	For
BNY Mellon	882,394	0	For
Dimensional	0	859,476	Abstain
JPMorgan	782,827	0	For
WILLIAM BLAIR FUNDS	0	756,519	Abstain
Charles Schwab	448,232	0	For
AIG/SunAmerica	0	261,088	Abstain
Bridge Builder Trust	244,362	12,039	For
Fidelity	63,035	181,306	Abstain
Direxion Shares ETF Trust	0	229,799	Abstain
OLD WESTBURY FUNDS INC	0	216,180	Abstain
Brighthouse	179,224	19,786	For
Equitable	112,469	59,444	For
TIAA	168,671	0	For
Jackson National	141,214	12,931	For
AMERICAN BEACON FUNDS	138,146	0	For
Columbia Threadneedle	132,700	0	For
FRANKLIN STRATEGIC SERIES	119,862	0	For
Global X	104,320	0	For
First Trust	0	96,906	Abstain

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

3. Election of Class III Directors: Robert Chess

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

60% Majority: yes · of votes cast

FOR 60%WITHHELD 40%

FOR: 27,503,789WITHHELD: 18,648,370

TWIST BIOSCIENCE CORP.’s own tally for this item (“Elect Director: Robert Chess”): 27,503,789 for, 18,648,370 withheld, per its Form 8-K filed 2024-02-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 57,779,000 outstanding shares: 47.6% for, 32% withheld (80% of the company cast a for/withheld vote).

The 72 asset managers below cast 100% of the shares they voted on this item FOR (17,450,548 for, 0 against).

FOR 70%ABSTAIN 30%

FOR: 17,450,548 (69.5%)ABSTAIN: 7,641,895 (30.5%)

Largest asset managers voting on “Election of Class III Directors: Robert Chess” at TWIST BIOSCIENCE CORP., 2023-2024
Asset manager	For	Abstain	Vote
ARK ETF Trust	6,775,445	0	For
Vanguard	5,376,144	0	For
State Street	1,243	1,993,491	Abstain
Artisan	1,611,932	0	For
BlackRock	1,223,059	0	For
Invesco	0	930,956	Abstain
BNY Mellon	0	882,394	Abstain
Dimensional	0	859,476	Abstain
JPMorgan	782,827	0	For
WILLIAM BLAIR FUNDS	0	756,519	Abstain
Charles Schwab	448,232	0	For
AIG/SunAmerica	0	261,088	Abstain
Bridge Builder Trust	244,362	12,039	For
Fidelity	63,035	181,306	Abstain
Direxion Shares ETF Trust	0	229,799	Abstain
OLD WESTBURY FUNDS INC	0	216,180	Abstain
Brighthouse	0	199,010	Abstain
Equitable	112,469	59,444	For
TIAA	168,671	0	For
Jackson National	0	154,145	Abstain
AMERICAN BEACON FUNDS	138,146	0	For
Columbia Threadneedle	0	132,700	Abstain
FRANKLIN STRATEGIC SERIES	119,862	0	For
Global X	25,987	78,333	Abstain
First Trust	0	96,906	Abstain

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

4. RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING SEPTEMBER 30, 2024.

AUDIT-RELATED

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.9%

The 72 asset managers below cast 100% of the shares they voted on this item FOR (25,085,279 for, 0 against).

FOR: 25,085,279 (100.0%)ABSTAIN: 7,164 (0.0%)

Largest asset managers voting on “RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCA” at TWIST BIOSCIENCE CORP., 2023-2024
Asset manager	For	Abstain	Vote
ARK ETF Trust	6,775,445	0	For
Vanguard	5,376,144	0	For
State Street	1,994,734	0	For
Artisan	1,611,932	0	For
BlackRock	1,223,059	0	For
Invesco	930,956	0	For
BNY Mellon	882,394	0	For
Dimensional	859,476	0	For
JPMorgan	782,827	0	For
WILLIAM BLAIR FUNDS	756,519	0	For
Charles Schwab	448,232	0	For
AIG/SunAmerica	261,088	0	For
Bridge Builder Trust	256,401	0	For
Fidelity	244,341	0	For
Direxion Shares ETF Trust	229,799	0	For
OLD WESTBURY FUNDS INC	216,180	0	For
Brighthouse	191,846	7,164	For
Equitable	171,913	0	For
TIAA	168,671	0	For
Jackson National	154,145	0	For
AMERICAN BEACON FUNDS	138,146	0	For
Columbia Threadneedle	132,700	0	For
FRANKLIN STRATEGIC SERIES	119,862	0	For
Global X	104,320	0	For
First Trust	96,906	0	For

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

5. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTESSECTION 14A SAY-ON-PAY VOTESSECTION 14A SAY-ON-PAY VOTESSECTION 14A SAY-ON-PAY VOTES

81% fund support · no official result

FOR 81%AGAINST 19%

The 5 asset managers below cast 81% of the shares they voted on this item FOR (1,662,903 for, 377,840 against).

FOR: 1,662,903 (81.5%)AGAINST: 377,840 (18.5%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at TWIST BIOSCIENCE CORP., 2023-2024
Asset manager	For	Against	Vote
JPMorgan	1,632,770	0	For
NORDEA INVESTMENT MANAGEMENT AB	0	377,148	Against
ADVISORY RESEARCH INC	29,833	0	For
Desjardins Global Asset Management Inc.	0	692	Against
TD ASSET MANAGEMENT INC	300	0	For

Largest TWIST BIOSCIENCE CORP. shareholders voting in 2023-2024

Ranked by the number of TWIST BIOSCIENCE CORP. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 57,779,000 shares outstanding at the time of that meeting.

Top TWIST BIOSCIENCE CORP. shareholders by shares voted, 2023-2024
#	Asset manager	% of shares outstanding
1	ARK ETF Trust	11.73%
2	Vanguard	9.48%
3	State Street	8.76%
4	Artisan	7.89%
5	Nikko Asset Management Americas, Inc.	5.60%
6	BlackRock	5.34%
7	WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC	4.89%
8	Invesco	3.54%
9	Maryland State Retirement & Pension System	3.46%
10	Man Group plc	2.83%

Reported TWIST BIOSCIENCE CORP. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

TWIST BIOSCIENCE CORP. beneficial owners on record for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
ARK Investment Management LLC	12.48%	13G
BlackRock	10.69%	13F
Vanguard Group	9.98%	13F
State Street Corporation	7.66%	DEF14A
JPMorgan Chase & Co.	6.63%	DEF14A
William Blair Investment Management, LLC	6.14%	13G
FMR LLC	5.34%	DEF14A
Nikko Asset Management Americas, Inc.	5.08%	DEF14A
Invesco	4.25%	13F
Millennium Management	3.85%	13F

Percentages above are of 57,779,000 shares outstanding, as reported by TWIST BIOSCIENCE CORP. on its Form 10-Q dated 2023-12-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from TWIST BIOSCIENCE CORP.’s 10-Q dated 2023-12-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At TWIST BIOSCIENCE CORP.'s shareholder meeting held 2024-02-06, in the 2023-2024 proxy season, 258 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,266 separate fund positions. Their filings are grouped here into 5 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. TWIST BIOSCIENCE CORP.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named… — the reporting funds cast 94% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

TWIST BIOSCIENCE CORP. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.